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Salicylic acid (SA) is an important plant hormone that
regulates many aspects of plant growth and
development, as well as resistance to (a)biotic stress.
Efforts to identify SA effector proteins have revealed
that SA binds to and alters the activity of multiple
plant proteins—this represents a shift from the
paradigm that hormones mediate their functions via
one or a few receptors. SA and its derivatives also
have multiple targets in animals; some of these
proteins, like their plant counterparts, are associated
with pathological processes. Together, these findings
suggest that SA exerts its defense-associated effects in
both kingdoms via a large number of targets.thermogenesis, whereas 31 other SA analogs did not. SA
induces thermogenesis primarily by stimulating the mito-What is the plant hormone salicylic acid?
Salicylic acid (SA; 2-hydroxybenzoic acid) is one of many
phenolic compounds (defined as compounds containing
a benzene ring bearing one or more hydroxyl groups)
that are synthesized by plants. Despite the diversity and
ubiquity of plant phenolics, these compounds were trad-
itionally assumed to be rather unimportant, secondary
metabolites. However, phenolics were subsequently
shown to be involved in many important processes, in-
cluding lignin and pigment biosynthesis, allelopathy, and
the regulation of responses to abiotic and biotic stresses
[1]. SA, for example, is a critical hormone that plays dir-
ect or indirect roles in regulating many aspects of plant
growth and development, as well as thermogenesis and
disease resistance [2]. Beyond its functions in plants, SA
and its acetylated derivate (commonly known as aspirin)
are important pharmacological agents for humans. SA is
commonly used to treat warts, acne, and psoriasis, while
aspirin is one of the most widely used medications in* Correspondence: dfk8@cornell.edu
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and inflammation, as well as reducing the risk of heart
attack, stroke, and certain cancers [3–5].How was SA’s status as a hormone discovered?
The first evidence that SA is a plant hormone came from
studies of voodoo lily (Sauromatum guttatum Schott) [6].
During blooming, the voodoo lily inflorescence exhibits
two episodes of thermogenesis (heat production). These
events increase the surface temperature of the inflorescence
by 12 and 10 °C and are thought to volatilize compounds
that attract/stimulate insect pollinators. Internal SA levels
increased ~100-fold prior to each episode [7]. Externally
supplied SA and two closely related analogs also induced
chondrial alternative respiratory pathway [8]. This pathway,
unlike the cytochrome respiratory pathway, generates ATP
at just one step and releases the remaining energy from
electron flow as heat. Interestingly, SA treatment also in-
duces the expression of alternative oxidase and/or the
alternative respiratory pathway in non-thermogenic plant
species [9, 10].
The year after SA’s function in thermogenesis was
elucidated, its role as a defense signaling hormone was
documented (see below). SA also has long been pro-
posed as a signal for flowering [11]. Consistent with this
possibility, the early flowering phenotype observed in
several Arabidopsis mutants correlates with, and is
dependent on, elevated SA levels [12–15]. In addition,
flowering was delayed in one study of SA-deficient
Arabidopsis [16], although others failed to observe this
phenomenon [17, 18]. Interestingly, several proteins that
regulate both flowering and resistance signaling have
been identified [12, 13, 15, 17–21]. While this finding
suggests an interconnection between flowering and dis-
ease resistance [22], it is clearly complex: some of these
proteins regulate both resistance and flowering in anis distributed under the terms of the Creative Commons Attribution 4.0
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resistance via an SA-dependent pathway but positively
or negatively regulate flowering via an SA-independent
mechanism.
How do plants resist pathogen infection?
Although plants lack the circulating immune cells found in
vertebrates, they do possess an innate immune system that
detects and limits pathogen colonization [23–25]. One
branch of this system uses pattern recognition receptors
(PRRs) on the plant cell surface to survey for molecules
containing characteristic patterns that are unique to, and
broadly conserved in, microbes. Detection of these patho-
gen-/microbe-associated molecular patterns (PAMPs/
MAMPs) leads to activation of pattern-triggered immunity
(PTI). In many cases, PTI prevents further pathogen
colonization. However, some pathogens have evolved
effector proteins that suppress PTI. These pathogens are
combatted via effector-triggered immunity (ETI), which
comprises the other branch of the innate immune system.
ETI is activated when plant-encoded resistance (R) pro-
teins, which are generally located within the plant cell,
directly or indirectly recognize their cognate pathogen-
encoded effectors. Both PTI and ETI are associated with
the activation of defenses in the inoculated tissue, including
the generation of reactive oxygen species (ROS), increases
in intracellular Ca2+ concentrations, activation of mitogen-
activated protein kinases (MAPKs), increased expression of
various defense-associated genes, synthesis of antimicrobial
compounds and accumulation of SA [26, 27]. Generally,
ETI induces these defenses more rapidly and intensely than
PTI. ETI also is usually associated with necrotic lesion
formation, which may help restrict pathogen movement
from the infection site. Subsequent to these events, ETI
and PTI can induce immune responses in the uninoculated
(systemic) portions of the plant, including a long-lasting,
broad-spectrum resistance called systemic acquired resist-
ance (SAR) [2, 23, 28].
How was SA’s role as a hormone signaling disease
resistance discovered?
Since the late 1970s, it was known that applying SA to
tobacco plants induces defense gene expression and en-
hances resistance to viral infection [29]. However, SA’s role
as an internal signal for disease resistance was not demon-
strated until 1990, when rises in SA levels were detected
prior to the development of local and/or systemic disease
resistance in tobacco and cucumber [30, 31]. Analyses of
tobacco and Arabidopsis unable to accumulate SA (due to
various mutations or expression of SA-degrading en-
zymes) confirmed that SA is required for PTI, ETI, and
SAR [2]. Grafting studies using SA-deficient or wild-type
(wt) tobacco further indicated that while SA accumulation
is required in the uninfected leaves for SAR development,SA is not the mobile SAR-inducing signal that travels
from the inoculated to systemic leaves [32, 33]. SA’s role
as a defense signal has been extended to many plant spe-
cies. However, there are conflicting reports regarding its
role in some monocots [2], as well as in plants that consti-
tutively accumulate high levels of SA (such as potato and
rice); its role in some plant species also appears to vary
depending on the pathogen [34–37].
It should be noted that SA is one of several plant hor-
mones involved in signaling defenses against microbial
pathogens [38, 39]. The SA-mediated defense signaling
pathway is activated following infection by biotrophic
pathogens, which require living host tissue. By contrast,
attack by necrotrophic pathogens, which feed on dead
tissue, induces a distinct defense pathway that is regu-
lated by the plant hormones jasmonic acid (JA) and
ethylene. The SA- and JA/ethylene-mediated defense
pathways undergo extensive cross-talk; their interactions
are generally antagonistic.
How do plants synthesize SA?
Plants utilize the isochorismate (IC) and the phenylalan-
ine ammonia-lyase (PAL) pathways to synthesize SA, as
well as many other important compounds (Fig. 1; for
more information, see [40]). Although neither route for
SA biosynthesis is completely understood, both are
known to require the primary metabolite chorismate
[40–42]. In the PAL pathway, PAL converts phenylalan-
ine (Phe) to trans-cinnamic acid (t-CA). Depending on
the plant species, t-CA is converted to SA via the inter-
mediates ortho-coumaric acid or benzoic acid (BA). The
conversion of BA to SA presumably occurs via BA 2-
hydroxylase. The IC pathway was identified based on the
hypothesis that plants synthesize SA via a pathway
analogous to that of some bacteria [43]. Indeed, genes
encoding isochorismate synthase (ICS), which converts
chorismate to isochorismate, have been identified in
many plant species. However, no plant gene correspond-
ing to bacterial isochorismate pyruvate lyase, which
converts isochorismate to SA and pyruvate, has been
identified. Following its synthesis, Arabidopsis ICS1 is
imported to the chloroplast stroma, where SA synthesis
occurs [44].
Demonstrating the IC pathway’s importance, Arabidopsis
ics1 mutants (also designated SID2 or EDS16) accumulate
90–95% less pathogen-induced SA and display decreased
disease resistance [43, 45, 46]. Similarly, pathogen-induced
SA was suppressed in ICS-silenced tomato and Nicotiana
benthamiana [47, 48]. Furthermore, diverse pathogens se-
crete chorismate- or isochorismate-metabolizing enzymes
that promote virulence by suppressing plant SA accumula-
tion [49, 50]. Since Arabidopsis mutants defective for both
ICS genes lack ICS activity but accumulate low SA levels
[51], an alternative, presumably PAL-dependent, pathway
Fig. 1. Plants have two pathways for SA production, the isochorismate (IC) pathway and the phenylalanine ammonia-lyase (PAL) pathway. Enzymes
involved in SA biosynthesis are abbreviated as follows: AAO aldehyde oxidase, BA2H benzoic acid 2-hydroxylase, CM chorismate mutase, ICS isochorismate
synthase, IPL isochorismate pyruvate lyase, and PAL phenylalanine ammonia-lyase. Question marks indicate that the enzyme responsible for the indicated
conversion has not yet been definitively identified
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sis, tobacco, and pepper exhibited reduced pathogen-
induced SA accumulation and disease resistance, whereas
Arabidopsis overexpressing CaPAL1 from pepper dis-
played increased pathogen-induced SA accumulation and
resistance [33, 52, 53]. It should be noted, however, that
pathogen-induced SA accumulation still occurs in PAL-
suppressed plants, while it is largely abrogated in ICS-
deficient plants. Whether PAL suppression affects SA
accumulation by impacting the phenylpropanoid pathway
or via an indirect effect on SA precursors, such as choris-
mate, is unclear [52].How is SA synthesis regulated?
Analyses of Arabidopsis mutants have identified several
proteins required for pathogen-induced SA accumulation,
including enhanced disease susceptibility 1 (EDS1) and
phytoalexin deficient 4 (PAD4), which are lipase-like pro-
teins, and non-race-specific disease resistance 1 (NDR1), a
glycophosphatidyl inositol-anchored plasma membrane
protein [2, 40]. EDS1 forms cytoplasmic- and nuclear-
localized complexes with various resistance-associated pro-
teins [54, 55], including PAD4 [56]. During ETI, the nuclearpool of EDS1 increases rapidly; this precedes/coincides with
ICS1, PAD4, and EDS1 upregulation [57]. While EDS1,
PAD4, and SA comprise a positive feedback loop [56], the
mechanism through which EDS1/PAD4 influence ICS1
expression is unknown.
Several transcription factors (TFs) that positively regu-
late ICS1 expression have been identified [26, 58], in-
cluding calmodulin-binding protein 60 g (CBP60g) and
its homolog SAR deficient 1 (SARD1) [59, 60], WRKY28
[61], teosinte branched1/cycloidea/PCF 8 and 9 (TCP8
and 9) [62], NTM-like 9 (NTL9) [63], and CCA1 hiking
expedition (CHE; also designated TCP21) [63, 64]. Ca2+
is implicated in CBP60g [65] and WRKY28 [66] activa-
tion, suggesting a mechanism linking pathogen-induced
Ca2+ influxes with SA biosynthesis [26]. NTL9 is prefer-
entially expressed in guard cells and is required for PTI-
associated stomatal immunity, and CHE, a component
of the circadian clock, regulates both circadian oscilla-
tion of ICS1 expression and its systemic induction dur-
ing SAR. Interestingly, TCP8 interacts with several other
TCPs and ICS1-associated TFs [62]; these interactions
could confer nuanced ICS1 expression and also form
regulatory nodes between different signaling pathways
[63]. Transcriptional repressors of ICS1 include ethylene
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TFs, ANAC019, ANAC055, and ANAC072 [58]. Since
these TFs also regulate JA and ethylene signaling, they
may mediate cross-talk between these pathways.
Interestingly, a chloroplast-localized, calcium-sensing
receptor (CAS) is required for full activation of various
ETI-/PTI-induced defenses, including SA accumulation,
stromal Ca2+ fluxes, stomatal closure, nuclear-encoded
defense gene expression, and pathogen resistance [67].
Although the mechanism(s) through which CAS exerts
its effects is unclear, these findings suggest that retro-
grade signals from chloroplasts also regulate SA biosyn-
thesis and immunity [27].Fig. 2. SA undergoes many modifications in plants. The level of biologicall
enzymes that convert it to biologically inactive derivatives (reviewed in [40
interconversions are indicated by solid arrows. The prodrugs salicin, which
depicted; their conversion to SA in animals is indicated by broken arrows. M
a prodrug in humans; thus, the in planta conversions are depicted by solid
a dashed line. Question marks indicate either that the reaction steps have n
conversion has not yet been definitively identified. In animals, aspirin is rapHow are cytosolic SA levels regulated?
After synthesis in the chloroplast, SA is transported to the
cytosol where it signals immune responses. In Arabidop-
sis, SA export is likely mediated by EDS5 (also designated
SID1), a chloroplast envelope-localized member of the
multidrug and toxin (MATE) transporter family [68, 69].
Once in the cytoplasm, SA can undergo various modifica-
tions that generally render it inactive (Fig. 2) [40, 41, 58].
These modifications are thought to help regulate the level
of biologically active SA in the cytoplasm, provide a
rapidly accessible source of SA and/or facilitate SA trans-
port throughout the plant. Maintaining low cytoplasmic
SA levels except during immune signaling is critical, asy active SA in the cytoplasm is regulated by an array of modifying
]). Shown here are the structures of SA and its derivatives; their
is a natural salicylate, and aspirin, a synthetic SA derivative, are also
ethyl salicylate (MeSA) is both a transported form of SA in planta and
arrows, while the human conversion of the prodrug is represented as
ot yet been identified or that the enzyme responsible for the indicated
idly converted to SA with a half-life (t1/2) of approximately 20 min
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by shunting both energy and resources away from growth
and reproductive processes [70]. Glucosylation of SA at its
hydroxyl group generates SA 2-O-β-D-glucoside (SAG),
while glucosylation at its carboxyl group produces salicyl-
ate glucose ester (SGE). SAG is transported to the vacuole,
where it serves as a non-toxic storage form that can be hy-
drolyzed to release free SA following pathogen attack.
Methylation of SA generates methyl SA (MeSA). MeSA is
a phloem-mobile SAR signal that travels from the infected
leaf to the systemic tissues, where it activates resistance
following its conversion back to SA [71]. Pathogen-
infected Arabidopsis also accumulate 2,3-dihydroxyben-
zoic acid (2,3-DHBA) and, to a lesser extent, 2,5-DHBA
[72]. Conversion of SA to 2,3-DHBA is mediated by SA 3-
hydroxylase (S3H; also termed DLOL1) [73, 74]. Since s3h
mutants accumulate high levels of SA, S3H-mediated hy-
droxylation may be a critical mechanism for preventing
SA over-accumulation [73]. Formation of SA–amino acid
conjugates is yet another modification strategy [40].
Salicyloyl-aspartate (SA-Asp) has been identified in plants;
it is presumably synthesized by GH3.5 (also termed
WES1), a member of the GH3 acyl adenylase family [75].
Another GH3 family member, GH3.12 (also termed PBS3,
GDG1, and WIN3), conjugates 4-substituted benzoates to
Glu [76]. Since gh3.12 mutants display reduced pathogen-
induced SA/SAG accumulation and disease resistance,
and these phenotypes were rescued by SA, GH3.12 was
predicted to function upstream of SA synthesis/accumula-
tion [40]. Given that stress-treated gh3.12 mutants accu-
mulate elevated levels of SA-Asp, GH3.12 may increase
cytosolic SA levels by repressing SA-Asp synthesis.
What plant processes does SA affect?
In Arabidopsis, the basal level of total SA (consisting of
SA and SAG/SGE) in leaves ranges from 0.22–5 μg/g fresh
weight; in the Solanaceous species tobacco and potato it is
<0.4 μg/g fresh weight and <17 μg/g fresh weight, respect-
ively [77]. Given the wide range in basal SA levels between
(and even within) plant species, it is perhaps not surpris-
ing that conflicting reports have been published concern-
ing the effect of exogenously supplied SA on various plant
processes. Despite this caveat, exogenous SA has been
shown to affect resistance to biotic (pathogen-associated)
stress and tolerance to many abiotic stresses (drought,
chilling, heat, heavy metal, UV radiation, and salinity/os-
motic stress), as well as multiple aspects of plant growth
and development, including seed germination, vegetative
growth, flowering, fruit yield, senescence, thermogenesis,
stomatal closure, root initiation/growth, photosynthesis,
respiration, glycolysis, Krebs cycle, and the alternative re-
spiratory pathway [42, 78–81]. Some of these processes
are induced by SA in a concentration-dependent manner,
as they are activated by treatment with a low dose of SAand inhibited by a high dose. This phenomenon is likely
linked to SA’s role in regulating cellular redox status, as
low concentrations of SA induce low-level accumulation
of ROS, which serve as secondary signals to activate
biological processes. By contrast, high concentrations of
exogenous SA stimulate the accumulation of high levels
of ROS, which cause oxidative stress and cell death [2].
Currently, the mechanisms through which SA regulates
these non-immune plant processes are not well under-
stood, but they do appear to involve the coordinated effect
of SA and other plant hormones.
How does SA work—a few receptors or multiple
targets?
It is generally assumed that plant and animal hormones
signal downstream responses by binding to one or a small
number of receptors. Whether this paradigm can be ex-
tended to SA is currently unclear. In Arabidopsis, mem-
bers of the non-expressor of pathogenesis-related genes
(NPR) protein family were proposed to be SA receptors
[82–84]. SA binding to NPR1 (also designated NIM1 and
SAI1) may promote immune signaling by relieving seques-
tration of NPR1’s trans-activating domain (see below)
[83]. By contrast, NPR3 and NPR4 appear to be negative
regulators of immunity [82]. Identification of these puta-
tive SA receptors represents progress. However, several
lines of evidence argue that additional SA-binding pro-
teins (SABPs) mediate SA’s functions. First, some immune
responses are activated via an SA-dependent but NPR1-
independent pathway(s). Second, there is little evidence
that non-immune processes affected by SA are NPR1-
dependent. Indeed, nearly 30 SABPs have been identified;
these proteins exhibit a range of affinities for SA and their
activities are altered by SA binding [77, 85]. Given that SA
levels can vary dramatically between plant species and also
within a plant, depending on its developmental stage, the
tissue type, subcellular compartment, and exposure to
(a)biotic stress, it is possible that SA signals its many ef-
fects by interacting with different SABPs, depending on
their location and SA affinity [77]. This hypothesis repre-
sents a paradigm shift for how at least some hormones
function. We recently proposed that proteins whose activ-
ity is altered following hormone/ligand binding be termed
“targets”, and only a subset of targets that meet additional
criteria be designated “receptors”. Determining which cri-
teria must be met to qualify an SABP as an SA receptor
will be complicated since i) SA binding alters the activity
of many SABPs and ii) some SABPs exhibit comparably
high affinity as the proposed receptors NPR1 and NPR4,
while others display a low affinity similar to NPR3.
What is the best-defined SA signaling pathway?
SA signals defense responses via both NPR1-dependent
and NPR1-independent pathways; of these, the NPR1-
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npr1 mutants fail to activate immunity following SA treat-
ment or pathogen infection, indicating NPR1’s critical
importance for SA signaling [41, 58]. NPR1 contains two
domains mediating protein–protein interactions: a BTB/
POZ and an ankyrin repeat domain, as well as a C-
terminal trans-activating domain and nuclear localization
sequence [86]. In uninfected plants, NPR1 is predomin-
antly sequestered in the cytosol as oligomers. After infec-
tion, SA-induced changes in the cellular redox state reduce
NPR1 to monomers that are transported to the nucleus.
There, NPR1 co-activates transcription of immune-
associated genes [87]. For the defense marker gene patho-
genesis-related-1 (PR-1), NPR1 directly interacts with
members of the TGA transcription factor family [2, 26, 88].
PR-1 expression may be further regulated by interactions
between NPR1 and members of the non-inducible immun-
ity 1 (NIM)-interacting (NIMIN) family, and by proteins
proposed to function downstream of NPR1 [26, 88]. NPR1
also upregulates the expression of WRKY TFs, which regu-
late many immunity-associated genes [89]. WRKY binding
sites are located in the NPR1 and ICS1 promoters, suggest-
ing the presence of a feedback loop that fine-tunes SA
signaling [26].
To prevent spurious/inappropriate induction of immune
responses, NPR1 activity is tightly regulated. Besides nu-
clear translocation, SA binding at two cysteine residues
(Cys521 and Cys529) may regulate NPR1 activity by indu-
cing a conformational change that releases the trans-
activating domain from the inhibitory BTB/POZ domain
[83]. How this mechanism applies to plant species
whose NPR1 homologs lack Cys521 and Cys529 is
unclear [86, 90]. NPR1 activity also is regulated via
proteasome-mediated degradation [91]. This process
may be mediated by NPR3 and NPR4, which are adap-
tors for Cullin 3 ubiquitin E3 ligase [82]. NPR4 is
proposed to maintain low NPR1 levels in uninfected
cells. Following infection, SA disrupts the NPR1–NPR4
interaction, allowing NPR1 to accumulate and defense
signaling to occur. In cells containing sufficiently high
SA levels, NPR3 binds NPR1; this promotes NPR1 turn-
over, which optimizes defense activation and resets
NPR1 levels [82, 91].
How is SA research benefitting agriculture?
Synthetic pesticides have allowed growers to dramatically
increase crop yield and quality. However, these com-
pounds are often toxic and their overuse has led to patho-
gen resistance [92, 93]. An environmentally friendlier
strategy for reducing crop loss involves regulating SAR
[94]. SA is an effective SAR inducer, but its phytotoxicity
precludes widespread use [95]. Several synthetic com-
pounds (Fig. 3), including 2,6-dichloroisonicotinic acid
(INA), benzo(1,2,3)thiadiazole-7-carbothioic acid S-methylester (also termed benzothiadiazole; BTH or acibenzolar-
S-methyl), and probenazole (PBZ) and its active metabol-
ite 1,2-benzisothiazol-3(2H)-one 1,1-dioxide (BIT), induce
defense gene expression and SAR to a similar range of
pathogens as SA [96, 97]. PBZ and BIT activate SAR by
triggering the SA signaling pathway upstream of SA [98],
whereas INA and BTH are SA functional analogs [96, 99].
While treating plants or suspension cells with high
concentrations of SA or its functional analogs directly
induces defenses, low concentrations elicit little to no
response. Following subsequent infection, however, de-
fenses are activated more rapidly and/or strongly [100].
This phenomenon, termed priming, also occurs in sys-
temic leaves of plants exhibiting SAR. Although not fully
elucidated, the molecular mechanisms of priming likely in-
volve the accumulation of transcripts and/or inactive
forms of MAPKs, elevated levels of PRRs, and chromatin
remodeling [95]. This latter mechanism may also promote
the inheritance of defense priming.
In addition to SA, its functional analogs and PBZ/BIT,
other resistance-activating compounds that work at least
in part by inducing/priming SAR, have been identified
[96, 97, 101]. In the field, resistance triggered by SAR in-
ducers/primers can be broad-spectrum and long-lasting,
but it is rarely complete; disease reduction ranges from
20–85% [97]. Other drawbacks growers must currently
consider include i) the potential for reduced plant fit-
ness, which may be minimized by stimulating priming
versus direct induction [102], ii) variable efficacy, de-
pending on plant cultivar and dosage, and iii) the possi-
bility that SAR inducers will increase susceptibility to
necrotrophic pathogens, due to suppression of the JA
signaling pathway [96, 97]. Nevertheless, future efforts
to clarify the SA signaling pathway should provide in-
sights into how current SAR-inducing compounds can
be improved, as well as identify novel pathway compo-
nents that could be targeted by the next generation of
agrochemicals.
How did aspirin become a wonder drug?
Plants rich in SA and its derivatives, collectively termed
salicylates, have been used for medicinal purposes for
millennia. In the fourth century BC, willow leaves/bark
extracts were prescribed by Hippocrates to relieve fever
and the pain of childbirth [2]. Salicylate-rich plants were
also used by other ancient cultures, including the Baby-
lonians, Assyrians, and Chinese, as well as the indigen-
ous inhabitants of the New World [42]. Although willow
bark was a well-known folk remedy, its medicinal effects
were first studied clinically in the mid-1700s by the Rev-
erend Edward Stone [3]. In 1828, Johann Buchner puri-
fied the active ingredient in willow bark and named it
salicin (Fig. 2). Raffaele Piria subsequently demonstrated
that salicin could be split into a sugar and an aromatic
Fig. 3. SA and several structurally and/or functionally related synthetic compounds induce SAR. a The chemical structures are depicted. b BTH
treatment suppresses powdery mildew caused by Blumeria graminis in wheat. Arrows point to the white, powdery-like spots/blotches on the leaves
of untreated wheat (Control), which turn yellow and die, whereas the leaves of BTH-treated wheat remain healthy after infection. The picture in (b) is
copyrighted by the American Society of Plant Biologists and is reprinted from [112], and modified slightly, with the author’s and American Society of
Plant Biologists’ permission
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Latin name for white willow [77]. Around this time, high
levels of salicylates were detected in other medicinal
plants, such as meadowsweet, which contains both salicin
and MeSA—then called oil of wintergreen [3, 77]. These
“prodrugs” are converted to SA after digestion in humans/
animals [77]. Increased demand for SA in the mid-1800s
led to the commercial production of synthetic SA in 1874.
As SA’s price fell and its availability increased, its clinical
use expanded. However, SA’s negative side effects, particu-
larly stomach irritation, precluded long-term, high-dosageuse. Research by Felix Hoffmann revealed that acetylation
improved SA’s tolerability without affecting its medicinal
properties [3]. Bayer and Company began synthesizing
acetyl SA (ASA) in 1897 under the trade name aspirin,
which was generated by combining the “a” from acetyl and
“spirin” from the Latin name for meadowsweet (Spiraea
ulmaria). Today, aspirin is one of the most widely used
drugs in the world. In addition to treating fever, swell-
ing, pain, and inflammation, aspirin is used prophylac-
tically to reduce the risk of stroke, heart attack, and
certain cancers [3–5].
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The combined observations that i) aspirin irreversibly
inhibits the cyclooxygenases COX1 and COX2, ii) these
enzymes convert arachidonic acid into prostaglandins,
and iii) prostaglandins induce fever, pain, inflammation,
and swelling underpin the prevailing assumption that
aspirin works via COX1 and COX2 inhibition [103].
However, aspirin is rapidly metabolized to SA in the hu-
man body, and SA is a weak COX1/COX2 inhibitor.
Given the similarities between SA’s and aspirin’s pharma-
cological effects, other SA targets likely exist [77]. In-
deed, 13 additional potential targets of salicylates have
been identified. The SA/aspirin levels required to alter
most of these putative targets’ activities are near or
above toxic levels. In contrast, low micromolar SA levels
in vivo alter the disease-associated activities of high mo-
bility group box 1 (HMGB1) [104] and glyceraldehyde
3-phosphate dehydrogenase (GAPDH) [105]. HMGB1 is
an abundant chromatin-associated, non-histone protein
that regulates nucleoprotein complex assembly and chro-
matin condensation [106]. It also is a damage-associated
molecular pattern (DAMP) that triggers inflammation
and induces cytokine expression when released extracellu-
larly after tissue damage or necrosis. SA binding blocks
HMGB1’s pro-inflammatory activities [104]. Notably,
low SA levels, while unable to inhibit COX1/COX2 en-
zymatic activity, suppress HMGB1-mediated induction
of Cox2 expression.
The glycolytic enzyme GAPDH is another protein
whose secondary functions are affected at low SA concen-
trations. GAPDH likely plays a role in neurodegenerative
diseases via a cell death cascade that involves GAPDH,
nitric oxide, and the E3 ubiquitin ligase Siah [107]. SA
binding suppresses GAPDH’s ability to translocate to the
nucleus and induce cell death [105]. Additionally, GAPDH
enhances hepatitis C virus replication and/or translation
by binding the viral genome; SA binding to GAPDH
suppresses this activity [77]. Given that SA binding also
suppresses the ability of cytosolic Arabidopsis GAPDH to
promote plant virus replication [108] and the DAMP ac-
tivity of HMGB3, an Arabidopsis counterpart to HMGB1
[109], plants and animals share at least several disease-
associated SA targets.
Why might humans have so many SA targets?
SA is present in the urine and/or blood of humans who
have not recently consumed salicylate drugs and also in
a wide range of animals [110]. Since humans on a vege-
tarian diet contain greater levels of SA and its metabolite
salicyluric acid than non-vegetarians, consuming large
quantities of plants–and their associated salicylates–
appears to influence SA levels to some extent [111].
However, no correlation between blood SA levels and
diet was observed in herbivorous versus carnivorousanimals [110]. The presence or absence of gastro-
intestinal bacteria also did not affect serum SA levels.
Instead, radiotracer studies suggested that SA is synthe-
sized endogenously in humans using BA as a precursor
[110]. BA, in turn, may be synthesized endogenously
from phenylalanine or provided by the diet, since some
fruits and vegetables contain high concentrations of BA
and its salts. We previously hypothesized that the pres-
ence of low SA levels in animals, whether endogenously
synthesized or provided by the diet, led to the evolution
of multiple SA targets [77]. Given the myriad effects of
SA’s prodrug aspirin, others have speculated that SA is a
critical animal bio-regulator that plays a key role in or-
chestrating defense responses, analogous to its role in
plants [110]. If these possibilities are confirmed, future
studies will likely identify additional SA targets that are
shared in plants and animals.
What are the future directions of SA research?
Despite significant progress in elucidating the SA signal-
ing pathway for plant disease resistance, significant
knowledge gaps remain. Our understanding of the
mechanism(s) through which pathogen perception is
transduced by PRRs and R proteins into activation of
early cellular responses and SA synthesis is fragmentary.
Likewise, the enzymes involved in SA biosynthesis are
not fully identified and the role of the ICS versus PAL
pathways in different plant species remains unclear. The
mechanisms through which ICS1 expression is regulated,
both in the nucleus and via retrograde signals from the
chloroplast, also need to be determined. As for the sig-
naling pathway downstream of SA, a crucial line of study
will involve identifying SA targets/receptors and asses-
sing their function. These analyses, combined with the
development of in vivo SA detection techniques, should
provide tremendous insight into how SA exerts its myr-
iad effects. Elucidation of the SA signaling pathway
should benefit agriculture by suggesting strategies for
improving current SAR-inducing compounds, as well as
facilitating development of novel compounds that target
currently unidentified pathway components. Finally, the
discovery that animals contain multiple SA targets
(which may have emerged in response to low-level ex-
posure to endogenously synthesized and/or dietary SA)
opens new avenues for treating human diseases. Indeed,
SA-mediated inhibition of HMGB1’s pro-inflammatory
activities might explain the protective effects of low-dose
aspirin use. The identification of natural and synthetic
SA derivatives that suppress HMGB1’s and GAPDH’s
disease-associated activities more effectively than SA
suggests there is great potential for developing SA-based
drugs that are even more efficacious and/or have fewer
negative side effects [77]. In summary, it is highly likely
that SA’s targets in animals and plants will significantly
Dempsey and Klessig BMC Biology  (2017) 15:23 Page 9 of 11overlap. Characterizing these proteins should not only
clarify how SA induces its effects in both kingdoms, but
also suggest novel strategies for controlling pathological
processes.
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